zyxw
zyxw
zyxwvutsrqpo
zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
TECHNICAL REPORT
~~~~
Direct detection of Mycobacterium tuberculosis
in respiratory samples from patients in Scandinavia
by polymerase chain reaction
zyxwv
Tone T 0 n j u m ' ~ Lisbeth
~,
Klintx3, Tom Beyan*,/0rann Baann', Geir Furubeyl,
Maria Cristea4, Bjmn Petrini' and Sven Ho#ne$
Institute of Microbiology, University of Oslo, Rikshospitalet (National Hospital), Oslo, Norway;
'Department of Microbiology, Ullevil University Hospital, Oslo, Norway; 3Swedish Institute for
Infectious Disease Control, Stockholm, Sweden; 4Clinical Microbiology Laboratory, Karolinska
Hospital, Stockholm, Sweden
Objective: To investigate the use of DNA amplification by the polymerase chain reaction (PCR) for the detection of
Mycobacteriurn tuberculosis directly in human respiratory specimens.
zy
Methods: The PCR assay employed was the Amplicor M. tuberculosis Test (Roche Diagnostics, Switzerland), which
uses the 16s rDNA as the target template. Nine hundred and sixty samples from 741 patients in t w o clinical microbiology
laboratories in Norway and Sweden were processed by routine culture analysis and PCR.
Results: Of the 56 specimens containing cultivatable M. tuberculosis, 49 (87.5%) were detected by PCR. Among the 904
culture-negative specimens, 897 samples were negative also b y PCR and seven (0.8%) were positive by PCR. In
comparison with culture, the sensitivity, specificity, and positive and negative predictive values of PCR were 91.7%,
99.6%, 94.2% and 99.4% for laboratory 1 and 80.0%, 98.7%. 76.2% and 99.0% for laboratory 2, respectively. For both
laboratories combined the values were 87.5%. 99.2%. 87.5% and 99.2%.
Conclusions: These results indicate that multiple (two or three) respiratory samples from each patient should be tested,
to allow sufficient accuracy in detecting M. tuberculosis in the specimens. Still, the labor-intensive format of this test
necessitates strong clinical indications and patient prioritization t o provide a service feasible within the current limits of
routine laboratories.
zyxwvut
Key words: Tuberculosis, polymerase chain reaction (PCR), 16s rDNA, rapid diagnostics
detection and a high recovery rate of niycobacterial
cultures [2,3].Species-specific nucleic acid probes have
significantly improved the opportunity for rapid
confirmation of culture results for several mycobacterial
species [4]. Still, days to weeks may be required for
suficient growth for identification. The use of the
polymerase chain reaction (PCR) for species identification of mycobacteria, particularly A4. tuberculosis, from
early BACTEC cultures has been favorably explored
[5,61.
Several groups have previously validated PCR
assays for the identification of M . tuberculosis directly in
clinical specimens [7-111. Several nucleic acid targets
have rendered sufficient sensitivity and representative
species-specific differentiation, such as the 16s rKNA
gene 112,131, IS elements (14--161, and the genes
INTRODUCTION
There is clearly a demand for more rapid and reliable
laboratory methods for the diagnosis of Mycobacterium
tuberculosis infections for public health and therapeutic
reasons [l]. The introduction of the radiometric
BACTEC system represents a major improvement in
the cultivation of mycobacteria by providing rapid
zyx
*Corresponding author and reprint requests:
Tone Tgnjum, Institute of Microbiology, University of Oslo,
Rikshospitalet (National Hospital), Oslo, Norway
Tel: +47 22 86 95 20
Fax: +47 22 74 15 96
e-rnail: tone.tonjurn@rh.uio.no
Accepted 15 April 1996
127
128
zyxwvutsrqponml
zyx
C l i n i c a l M i c r o b i o l o g y a n d I n f e c t i o n , V o l u m e 2 N u m b e r 2, O c t o b e r 1 9 9 6
zyxwvuts
encoding the 32-kDa and 65-kDa proteins [7,17].
Nucleic acid amplification techniques other than P C R ,
such as transcription-mediated amplification [ 3.4,18]
and, more recently, strand displacement [19] and Qbeta-replicase probe amplification assays [20], are also
being widely used.
We evaluated the Amplicor P C R assay (R.oche,
Switzerland) for detection of M . tuberculosis directly in
respiratory specimens. The target D N A to be amplified
was the mycobacterial 16s rDNA signature region
[13,21]. The aim of our study was to establish whether
this test was useful for direct detection of M . tuberculosis
in respiratory samples in Scandinavian laboratories, one
in Norway and one in Sweden.
MATERIALS AND METHODS
Material
All routine clinical specimens submitted for cultivation
of mycobacteria were processed by standard procedures. The specimens in laboratory I were decontaminated by the N-acetyl-L-cysteine/NaOH method
[22]. Two volumes of NALC/NaOH solution (2%
NaOH, 1.45% sodium-citrate, 0.5% N-acetyl-Lcysteine) were mixed well with the specimen and
allowed to digest for 15 to 30 min at room temperature.
Ten volumes of 10 mM phosphate buffer (pH 6.8) were
added for dilution, before centrifugation at 3000,g for
15 min. In laboratory 2 the samples were decontaminated by the sodium lauryl sulfate method [23] and
centrifuged at 35008 for 30min. Sediments were
resuspended in 3 to 5 ml of phosphate-buffered saline.
Smears were prepared, stained according to ZiehlNielsen or with auramine, and examined for acid-fast
bacilli (AFB) by microscopy. Five hundred and eightytwo sputum samples and 378 bronchioalveolar lavage
(BAL) samples from 741 patients were processed. Five
hundred and forty-four samples were investigated by
laboratory 1 and 416 by laboratory 2.
Culture protocol
BACTEC Middlebrook 12B vials (Becton Dickinson
Diagnostic Instruments, Sparks, Md, USA) [2,3] were
inoculated with 0.5 mL of each specimen. The 12B
vials were monitored by using the BACTEC 460
radiometric reader (Becton Dickinson Diagnostic
Instruments) on a regular basis for 6 weeks. Once a 12B
vial attained a growth index (GI) of > = l o o , the
presence of AFB was confirmed by Ziehl-Nilsen
staining. Laboratory 2 inoculated each sample on
Lowenstein-Jenssen (LJ) medium. The P C R assay was
incorporated into the laboratory routine without any
change in practices, and specimens were processed 5 to
6 daydweek.
Culture identification
Hybridization assays were performed directly on lysed
AFB using commercially available nucleic acid probes
for the M . tuberculosis complex and M . avium-intracellulare (MAC) (Accuprobe, Gen-Probe, San Diego,
CA, USA) [4]. Mycobacterial species other than the M.
tuberculosis complex and MAC were identified by
conventional procedures.
PCR analysis
Sample preparation
One hundred microliters of the decontaminated
sputum or BAL was added to 500 pL of Tris-HC1 with
1% Triton X-100 and 0.05% sodium azide, mixed and
centrifuged at 1 2 , 5 0 0 ~for 10 min. The supernate was
carefully removed, and 100 pL of the lysis solution
containing 1% Triton X-100, 0.4% sodium hydroxide
and 0.05% sodium azide was added. The pellet was
dissolved by vortex mixing and incubated at 60 "C for
45 min. After centrifugation, 100 pL Tris-HC1 with
0.05% sodium azide was added. One positive control
containing M . tuberculosis D N A and three negative
buffer controls were included in each experiment for
reference purposes.
zyxwv
PCR amplification reaction
Genus-specific primers KY18 and KY75 derived to
correspond to a highly conserved region of the 16s
r R N A gene (rDNA) of mycobacteria were used to
amplify a 584-base-pair fragment (bases 15 to 598 of
the M. tuberculosis 16s rDNA sequence, accession no.
52917 in Genbank). Fifty microliters of each sample
were added to 50 pL of P C R reaction mixture
(Amplicor, Roche, Basel, Switzerland) containing
10 m M Tris-HC1,50 mh4 KCl, 2 mM MgC12,200 pM
concentrations of each deoxynucleotide triphosphate
(dATP, dCTP, dGTP and dUTP), 0.001% (w/v)
gelatin, uracil-N-glycosylase (UNG), biotinylated
primers, and 0.5 U of Ampli-Taq polymerase (PerkinElmer Cetus, Nonvalk, CT, USA). Each sample was
first heated a t 50 "C for 2 min, and then amplified in
two cycles of 20 s at 98"C, 20 s at 62°C and 45 s at
72"C, and then in 35 cycles of 20 s at 94"C, 20 s at
62°C and 45 s at 72°C in a thermal cycler (Perkin
Elmer Cetus TA9600). dUTP, instead of dTTF', was
used as a substrate for U N G in order to prevent
carryover of the amplified D N A [24]. Finally, samples
were heated at 72 "C for 5 min until further processing
to complete the initiated D N A polymerase activity
and not allow UNG, which could have survived the
extensive heating, to have an effect on dUTPcontaining PCR products.
zyxwvutsrqponm
zyxwvutsrqpo
zyxwvutsrqpon
zyxwvu
T @ n j u r ne t a l : P C R d e t e c t i o n o f M. t u b e r c u l o s i s
129
zyxwvutsrq
Hybridization reaction
After the PCK amplification process, the amplified
products were chemically denatured and added to a
microwell plate containing a bound, M . tubevculosisspecific oligonucleotide probe, KY 172T3. This probe
was selected from the hypervariable region of the 16s
rRNA gene 13,211. The biotin-labeled P C R products
were then hybridized to the probe and thus 'captured'.
Detection reaction
After washing to remove unbound material, an avidinhorseradish peroxidase (Av-HKP) conjugate was added
to the plate. After washing to remove the unbound
conjugate, the bound Av-HKP was reacted with
peroxide (H202) and tetraniethylbenzidine (TMB) to
form a color complex. The reaction was stopped by the
addition of weak acid. The optical density a t 450 nni
was measured in an automated microwell plate reader
and the results were compared to the cut-off value of
0.350. A clinical specimen with an
reading equal
to or greater than 0.35 is positive, and a specimen with
a reading less than 0.35 is negative for the presence of
M . tubwrulosis DNA.
Detection of M. tuberculosis by PCR
The same 960 respiratory specimens were tested for
presence of M. tubcrc~losisby thy nucleic acid aniplification method (PCR). In total, 49 of the 56 specimens
which yielded M . tuberculosis by culture were positive
for M . tubevculosis DNA by P C R (Table 1). PCK was
positive for an additional seven specinienr from four
patients, which were negative by culture. Based on the
findings in Table 1, the overall sensitivity, specificity,
and positive predictive and negative predictive values of
this particular P C R test in comparison with culture
were 87.5%1, 99.2'3'1, 87.5% and 99.294, respectively
(Table 2). The values of the P C R test were 91.7%,
99.6%, 94.2% and 99.4% for laboratory 1 and 80.096,
98.7%, 76.2% and 99.0% for laboratory 2, respectively
(Table 2).
N o positive result for the M . tuberculosis complex
was obtained by the P C K system for the specimens
which were positive for atypical niycobacteria or other
bacterial species grown in the BACTEC 12B or LJ
media. Four patients whose sputum specimens were
culture negative, but M. tuberculosis PCR-positive, had
other PCR-positive samples, a past history of tuberculosis and/or clinical response to recent antituberculosis
chemotherapy.
zyxwvutsr
zyxwvuts
Chemical prevention of PCR product contamination
The recommended procedures to prevent false-positive
reactions as a result of target or amplified product
DISCUSSION
contamination were followed.
Detection of mycobacteria by culture
In total, 88 specimens were positive by culture (9.2%)
(Table 1 ) . O f these, 56 (5.80/;,)
were M . tuberculosis
isolates from 33 patients. Moreover, 15 isolates of
MAC, 12 M . malinoense, two M . clielouae, and one M.
xcnopi were detected.
Table 1 Comparison of results obtained by culture and
I'CR in detection of M . ruhevcrrlosk in respiratory speciniens
in Scandinavia. The nunibers for laboratory 1 and 2 are
given on the upper line, and thc total numbcrs for both
laboratorics are given in bold type
Culture
Mtbf
I'CRf
PClITotal
33+16
49
3h+4
7
56
Culture M t b
Culture MOTT-
Culture MtbCulture MOTT+
2
" .
i
o+n
7
487 + 378
865
872
0
19+13
32
32
In comparison with culture, the sensitivity of PCK was
91.7% for laboratory 1 and 80.0% for laboratory 2,
respectively (Tables 1 and 2). In comparison with
previously published studies for direct detection of L\f.
tuberculosis by P C R , other groups have found that the
sensitivity of their P C R assays when cornpared with
culture ranged from 82% to 94% [7,14-171. Seven
samples in five patients were 2.I. tubevc-trloris culture
negative and P C R positive and can as such be strictly
regarded as false positive. But when other hctors are
taken into account for evaluating the patient as ''if.
tcrbcvculosis positive' by having other samples poyitive
by culture and/or P C R or other factors indicating
tuberculosis, most of this specificity problem is
resolved.
zyx
Total
35+22
56
509+395
904
960
.'Other s.iinplcs froin these two patients wcrc M. tcrbercrtlosi~culture
po"t1ve.
"lieteyting by PCIX (AmpliCor) gave a positive result in one of
thew samples; PCK confirmation testing by Roche in Hasel (blind
teTtirig) gave poqitive results in the remaining two wiiples.
Table 2 The sensitivity, specificit); and positive predictivc
value and negative predictive value of the PCR tmt as
compared to culture, based on the results in Tablc 1
Laboratory
Lhoratory 1
Laboratory 2
Laboratories
1 and 2
Sensitivity
(%)
Specificity
(9%)
zyx
zyx
Positivc
Negative
prcdictivc predictivc
value ('H,) v.iluc ('HI)
91.7
80.0
99.6
98.7
94.2
76.2
09 1
87.5
99.2
87.5
90.2
09.0
130
C l i n i c a l M i c r o b i o l o g y a n d I n f e c t i o n , V o l u m e 2 N u m b e r 2, O c t o b e r 1 9 9 6
Different decontamination procedures may account
for the major part of the discrepant sensitivity in
the two laboratories. Laboratory 1 used the NALC
decontamination procedure, while laboratory 2 used
the sodium dodecylsulfate (SDS) method. The NALC
procedure is clearly the decontamination method
recommended by the Amplicor manufacturing
company and for P C R and other amplification
techniques [14,15,18]. The higher sensitivity of P C R
in comparison with culture for laboratory 1 could also
be due to less optimized culture techniques than in
laboratory 2, laboratory 1 using only BACTEC
detection and not including solid media [3]. Possibly,
recently documented batches of BACTEC vials with
reduced performance in cultivating both M . tuberculosis
and M O T T might be involved 1251. Other factors
include the time elapsed between sampling and
processing, sample handling, and the technical quality
of the sample preparation, lysis and P C K set-up. The
samples examined by P C R by laboratory 2 were
transported after decontamination and sample
preparation and frozen at -70 "C before P C R analysis.
The sample lysis and pretreatment procedure with
Triton X-100 and optimized buffering clearly facilitates
direct detection of M. tuberculosis by P C R . The U N G
enzyme inactivates up to lo9 copies of uracilcontaining M. tuberculosis amplified D N A [24]. This
reduced the likelihood of false-positive results arising
due to contamination with pre-existing P C R products.
Furthermore, the inclusion of the hybridization event
ensured that only M . tuberculosis-specific P C R products
were detected, increasing the overall specificity of the
test. These actions, in addition to careful laboratory
precautions in sample processing and work habits, have
now minimized the occurrence of false-positive PCR
results.
Factors lowering the sensitivity of P C R are
interfering substances present in clinical specimens
[7,11,15] and inadequate amounts of the microbial
DNA to be detected. An uneven distribution of
bacteria or DNA, even after lysis of the material, as may
particularly apply to mucous material in sputum, may
cause an arbitrary sampling effect. In our hands, the
P C R assay worked just as well directly on respiratory
specimens which were not subjected to decontamination (unpublished results). The elimination of factors
inhibitory for P C R in clinical specimens remains a
challenge in the use and acceptance of all amplification
assays in the diagnostic setting. Certainly, the inclusion
of a positive amplification control test is useful to assess
the inhibiting factors which may be present in clinical
material.
Despite promising results of numerous published
reports, the routine use of P C R to detect M. tuberculosis
zyx
directly in clinical specimens has been hampered for a
variety of reasons, such as contamination, expense, and
lack of sensivity and/or specificity [7,9-11,13,15,17].
In addition, the routine use of P C R in the clinical
laboratory sets limitations because of the complex procedures required for amplification, such as cumbersome
sample preparation and detection methods.
Still, using P C R in the identification of M.
tuberculosis directly in clinical samples offers unique
improvements in this diagnostic field. This P C R assay
offers a sensitive and specific test for M. tuberculosis
performed within 5 to 6 h. More automation and lower
assay expenses are required. For the future, this and
other amplification techniques can facilitate the direct
detection of the infecting agent and its antibiotic
susceptibility pattern [26], as well as epidemiological
mapping [27]. Potentially, all of these goals can be
achieved in one single multiplex assay.
zyxwvutsr
zyx
References
1. Bloom BR, Murray CJL. Tuberculoqis: commentary on a
reemergent killer. Science 1992; 257: 1055-63.
2. Middlebrook C , Reggiardo Z , Tigerit WD. Automatable
radiometric detection of growth of Mycobacterium tuberculosis
in selective media. Am Rev Respir Dis 1977; 115: 1066-9.
3. Morgan MA, Horstmeier CD, DeYoung D R , Roberts GD.
Comparison of a radiometric method (BACTEC) and
conventional culture media for recovery of niycobacteria
from smear-negative specimens. J Clin Microbiol 1983; 18:
384-8.
4. Evans KD, Nakasone AS, Sutherland PA, de la Maza LM,
Peterson EM. Identification of Mycobacterium tuberculosis and
Mycobacteriuni avium-M. iutracellulare directly from primary
BACTEC cultures by using acridium-ester-labeled DNAprobes. J Clin Microbiol 1992; 30: 2427-31.
5. Cormican M, Barry GT, Gannon F, Flynn J. Use of the
polymerase chain reaction for early identification of
Mycobacterium tuberculosis in poqitive cultures. J Clin Pathol
1992; 45: 601-4.
6. Morris A, Reller L, Devlin B. Clinical usefulness of
detecting growth of Mycobacterium tuberculosis in positive
BACTEC vials using PCR. J Clin Pathol 1994; 47: 190.
7. Brisson-Noel A, Gicquel B, Lecossier D, Levy-Frebault V,
Nassif X, Hance AJ. Rapid diagnosis of tuberculosis by
amplification of mycobacterial DNA in clinical samples.
Lancet 1989; 336: 1069-71.
8. De Wit 11, Steyn L, Shoemaker S, Sogin M. Direct detection
of Mycobacterium tuberculosis in clinical specimens by DNAamplification. J Clin Microbiol 1990; 28: 2437-41.
9. Forbes BA, Hicks KES. Direct detection of Mycobacterium
tubercrrlosis in respiratory specimens in a clinical laboratory
by polymerase chain reaction. J Clin Microbiol 1993; 31:
1688-94.
10. Nolte FS, Metchock B, JMcGowan JE, et al. Direct
detection of Mycobactwium tuberculosis in sputum by polymerase chain reaction and DNA hybridisation. J Clin
Microbiol 1993; 31: 1777-82.
zyxwv
zy
zyxw
zyxwvutsrqpon
zyxwvutsr
zyxwvutsrq
T o n j u m e t a l : P C R d e t e c t i o n of
zyxwvutsrq
M. tuberculosis
11. Sjohring V, Mecklenburg A, Andersen AD, Mioriier H.
I’olymerase chain reaction for detection of Mycobnrt~riunz
fub?rcfth;s. J C h i Microbiol 1990; 28: 2201 )-4.
12. I3ixidinghau.i n, Ilogall T, Flohr T, Blocker H, Dattger E.
Detection and identification of niycobacteria by aniplificatioii of rllNA. J Clin Microbiol 1990; 28: 1751-9.
13. II’Am~itoKF, Wallniann AA, Hochstein LH, et al. Rapid
diagnosis of pulmonary tuberculosis by using the Kochc
Amplicor M y r ~ ~ ? f f r f e ~rttlieuritlosis
ii~nI
I’CR test. J Clin Mici-oblol 1995; 33: 1832-4.
14. Abe C , Hirano K, Wada M, et al. Detection of Myrobarteriunr
tfrbercir/osis in clinical specimens by polymerase chain reaction
dnd Gen-Probe diiiplified niycobacterium tuberculosis direct
test. J Clin Microbiol 1993; 31: 3270-4.
15. Clarridge JE 111, Shaivar K M , Shinnick T, Plikaytis DB.
Large-scale use of polymerase chain reaction for detection of
.2/lyrobartcrirrm tubrrciihsis in a routine niycobacteriology
laboratory. J Clin Microbiol 1993; 31: 2040-56.
16. Eisenach KD, Cave MD, BatesJH, CrawfordJT. Polymerare
chain reaction amplification of a repetitive DNA sequence
specific for Mycabncteriunr fiuberrulosis. J Infect Dis 1990; 161:
977-81.
17. Soini H, Skurnik M, Liippo K, Tala E, Vilganen MK.
lktection and identification of niycobacteria by aniplification of A segment of the gene coding for the 32-kilodaltori
protein. J Clin Microbiol 1992; 30: 2025-8.
18. Jonas V, Alden MJ, Curry JI, et al. Detection and identification of Mycobirtcriunr tuhrrculosis directly froni sputum
sediments by amplification o f r l l N A . J Clin Microbiol 1993;
31: 2410-16.
19. Walker GT, Nadeau JG, Spear? PA, Schrani JL, Nycz C M ,
SIi.ink IlD. Multiplex strand displacement aniplification
131
(SDA) and detection of DNA sequences from ~ ~ 4 y r 1 i ~ i ~ ~ c t ~ , r i i t ~ ~ i
tithercuio.cis and other niycobactci-ia. Nucleic Acids lles 1994;
22: 2670-7.
20. Shah J, Liu J, Buxton D, et al. Lktcction of ,~)~niburrc,riztrrr
tubercu/~isisdirectly from spiked human sputuni by (2-beta
replicasr-amplified assay. J Clin Microbiol 1095; 33: 322-H.
21. Rogall T, Flohr T, Bottger EC. Ilifferentiatiou of Myrcihucf~~rrrrwz
species by direct sequencing of amplified DNA.
J Gen Microbiol 1990; 136: 1915-20.
22. Kubica GPW, Dye E, C h h n ML, Middlcbrook G. Sptituni
digestion and decontamination with N-acrty-L-cysteinrsodiumhydroxide for culture of rnvcobacteria. Am l l e v
Respir Ilis 1963; 87: 775-9.
23. Isenberg H D (cd.) Clinical 1nicrobiolog)- procedure5 liandbook, vol. 1 . Washington DC: American Society for
Microbiology, 1992.
24. Longo MC, Beringer MS, Hartley JL. Use of uracil 1)NA
glycosylase to control carry-ovei- contamination i n polymerase chain reactions. Gene 1990; 93: 12.5-8.
25. ClarridgeJE 111, Ilaiiibo C. Subtle niediurn variations affect
results. ASM News 1995; 61: 271-2.
26. Tclenti A, Imboden l’, Marchcsi F, Schniidheini T, L3ddmrr
T. Dii-ect, automated detection of rifaiiipiii-re~istaiit .Myrcibnctrriitni tnbcrcnlo,sir by polymerase chain reaction and singlestranded conformation polymorphism analysi?. Antitiiicrob.
Agents Cheiiiother 1993; 37: 2054-8.
27. Lintori CL, Jalal H , Leeming JP, Millar M K . I<apId
discrimination ofA4yrcibacterium tuhercnlosis strains by ratidom
amplified polymorphic DNA analysis. J Clin Microbiol
1994; 32: 2169-74.
zyxwvu
zyxwvutsrqpo